
In cancer clinical trials, the standard end points include response rates, progression free and overall survival, zzso These evaluation criteria do not measure how the cancer and its treatment affect the quality of life of cancer zzso 

The relevant literature was reviewed for the purposes of determining when, how and why quality of life should be measured in cancer clinical zzso The resulting clinical benefits were also zzso 

Along with survival, quality of life is the main end point of comparative clinical zzso Its evaluation can provide physicians and patients with important information and help to identify a better zzso zzso questionnaires with forms for specific zzso types sites have been developed and have proven to be more sensitive to changes than generic zzso zzso evaluation before the start of treatment may be an important zzso factor, even independent from performance zzso Clinical benefit assessment presents important shortcomings and the clinical relevance of this evaluation should be interpreted with zzso 

Quality of life is a fundamental task of zzso zzso More studies are necessary to overcome the difficulties in assessing and interpreting this concept and the clinical benefits based on zzso 

